Aspira Women's Health Inc... (AWH)
Aspira Women's Health Statistics
Share Statistics
Aspira Women's Health has 29.76M shares outstanding. The number of shares has increased by 41.97% in one year.
Shares Outstanding | 29.76M |
Shares Change (YoY) | 41.97% |
Shares Change (QoQ) | 6.05% |
Owned by Institutions (%) | 6.4% |
Shares Floating | 21.28M |
Failed to Deliver (FTD) Shares | 32.74K |
FTD / Avg. Volume | 0.71% |
Short Selling Information
The latest short interest is 1.51M, so 8.53% of the outstanding shares have been sold short.
Short Interest | 1.51M |
Short % of Shares Out | 8.53% |
Short % of Float | 11.98% |
Short Ratio (days to cover) | 1.56 |
Valuation Ratios
The PE ratio is -0.76 and the forward PE ratio is -0.35. Aspira Women's Health's PEG ratio is 0.02.
PE Ratio | -0.76 |
Forward PE | -0.35 |
PS Ratio | 1.09 |
Forward PS | 0 |
PB Ratio | -3.89 |
P/FCF Ratio | -0.82 |
PEG Ratio | 0.02 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Aspira Women's Health.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.76, with a Debt / Equity ratio of -1.08.
Current Ratio | 0.76 |
Quick Ratio | 0.71 |
Debt / Equity | -1.08 |
Debt / EBITDA | -0.17 |
Debt / FCF | -0.23 |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $139.12K |
Profits Per Employee | $-198.39K |
Employee Count | 66 |
Asset Turnover | 1.67 |
Inventory Turnover | 11.36 |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -97.39% in the last 52 weeks. The beta is 2.01, so Aspira Women's Health's price volatility has been higher than the market average.
Beta | 2.01 |
52-Week Price Change | -97.39% |
50-Day Moving Average | 0.17 |
200-Day Moving Average | 0.72 |
Relative Strength Index (RSI) | 34.18 |
Average Volume (20 Days) | 4.61M |
Income Statement
In the last 12 months, Aspira Women's Health had revenue of 9.18M and earned -13.09M in profits. Earnings per share was -0.93.
Revenue | 9.18M |
Gross Profit | 5.48M |
Operating Income | -16.28M |
Net Income | -13.09M |
EBITDA | -16.19M |
EBIT | -16.28M |
Earnings Per Share (EPS) | -0.93 |
Balance Sheet
The company has 1.77M in cash and 2.76M in debt, giving a net cash position of -993K.
Cash & Cash Equivalents | 1.77M |
Total Debt | 2.76M |
Net Cash | -993K |
Retained Earnings | -531.4M |
Total Assets | 5.49M |
Working Capital | -1.28M |
Cash Flow
In the last 12 months, operating cash flow was -12.11M and capital expenditures -37K, giving a free cash flow of -12.15M.
Operating Cash Flow | -12.11M |
Capital Expenditures | -37K |
Free Cash Flow | -12.15M |
FCF Per Share | -0.86 |
Margins
Gross margin is 59.67%, with operating and profit margins of -177.28% and -142.61%.
Gross Margin | 59.67% |
Operating Margin | -177.28% |
Pretax Margin | -142.61% |
Profit Margin | -142.61% |
EBITDA Margin | -176.28% |
EBIT Margin | -177.28% |
FCF Margin | -132.32% |
Dividends & Yields
AWH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for AWH is $5.5, which is 6011.1% higher than the current price. The consensus rating is "Buy".
Price Target | $5.5 |
Price Target Difference | 6011.1% |
Analyst Consensus | Buy |
Analyst Count | 1 |
Stock Splits
The last stock split was on May 12, 2023. It was a backward split with a ratio of 1:15.
Last Split Date | May 12, 2023 |
Split Type | backward |
Split Ratio | 1:15 |
Scores
Altman Z-Score | -144.46 |
Piotroski F-Score | 5 |